美國(guó)ProteinOne  www.proteinone.com
ProteinOne公司位于美國(guó)馬里蘭州馬里蘭大學(xué)園區(qū)，主要研發(fā)和生產(chǎn)純化的活性蛋白質(zhì)和蛋白質(zhì)芯片平臺(tái)，應(yīng)用于研究實(shí)驗(yàn)室、醫(yī)學(xué)院校和制藥公司等單位。公司來(lái)自NIH的專(zhuān)家及一流的專(zhuān)業(yè)技術(shù)是質(zhì)量和信心的保證。
ProteinOne公司成立于2000年10月，創(chuàng)始人認(rèn)為在后基因組時(shí)代對(duì)純化活性蛋白和有關(guān)設(shè)備如通用蛋白芯片系統(tǒng)的需求越來(lái)越大。ProteinOne公司的目標(biāo)是在兩年內(nèi)提供300多種純化活性蛋白。
ProteinOne產(chǎn)品主要有：蛋白質(zhì)系列、客戶(hù)定義蛋白質(zhì)服務(wù)和蛋白質(zhì)芯片平臺(tái)。
公司提供客戶(hù)有活性的高純度重組蛋白和天然的哺乳動(dòng)物細(xì)胞內(nèi)蛋白。產(chǎn)品類(lèi)型包括普通轉(zhuǎn)錄因子、轉(zhuǎn)錄激活因子和輔助因子、mRNA前體處理因子、腫瘤抑制因子和其它腫瘤相關(guān)蛋白。

ProteinOne is a development stage biotechnology company doing business in Bethesda Maryland, USA. The primary aim of the company is to deliver purified, biologically active proteins to research labs, medical institutions and pharmaceutical companies via a Universal Protein Array (UPA) under development by the company to help companies with their drug discovery program.
The purified proteins will be sold in two different formats: through the patent pending UPA system, or Individually by request. The company’s aim is to include over 300 purified active proteins in our inventory within two years, and to successfully transfer from a prototype to an operationally complete model of the UPA.
ProteinOne's expertise in active protein production allows us to provide customers with functionally active and highly purified recombinant proteins as well as native protein fractions from mammalian cells. Our product lines include general transcription factors, transcriptional activators and coactivators, pre-mRNA processing factors, tumor suppressors and other cancer related proteins. 
ProteinOne was incorporated in Delaware in October 2000. The founders believe that there exists a tremendous need for both purified, functional proteins, and delivery devices such as the Universal Protein Array system, to extend the research and commercialization of Human Genome discoveries in the post-genomic world.
ProteinOne was formed with a strong management team solidified by scientific expertise from the National Institutes of Health (NIH), and has negotiated certain licenses for the UPA to be implemented at our discretion.
In 2001, ProteinOne entered the Technology Advancement Program (TAP) at the University of Maryland, an internationally recognized business incubator providing modern laboratory facilities and centralized university affiliation.
ProteinOne continues its growth and has established itself as a leader in the medical research field with their innovative protein bioreagents. The company graduated from the TAP in 2005 and now occupy their new laboratories and administrative offices in Bethesda, Maryland.